Pembrolizumab in PMBCL, allogeneic CD19 CAR T cells for pediatric B-cell ALL, and fetal iron overload in β-thalassemia
Blood Podcast
00:00
Allogenaic CAR T-Cells: An Alternative Root to Cure
Treatment-related toxicity was similar to what one might expect from autologous CAR T-cells. Ten of the 13 patients experienced CRS, and all were grade 1 in severity. The risk of severe or life-threatening GVHD also remains a concern.
Transcript
Play full episode
